nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active commuting and obesity in mid-life: cross-sectional, observational evidence from UK Biobank
|
Flint, Ellen |
|
2016 |
4 |
5 |
p. 420-435 16 p. |
artikel |
2 |
Active commuting: an easy and effective way to improve health
|
Andersen, Lars Bo |
|
2016 |
4 |
5 |
p. 381-382 2 p. |
artikel |
3 |
Calcified nodules on fingers in primary hyperoxaluria type 2
|
Yamanouchi, Masayuki |
|
2016 |
4 |
5 |
p. 468- 1 p. |
artikel |
4 |
Correction to Lancet Diabetes Endocrinol 2016; published online March 1. http://dx.doi.org/10.1016/S2213-8587(16)00079-6
|
|
|
2016 |
4 |
5 |
p. e5- 1 p. |
artikel |
5 |
Correction to Lancet Diabetes Endocrinol 2015; published online Nov 2. http://dx.doi.org/10.1016/S2213-8587(15)00372-1
|
|
|
2016 |
4 |
5 |
p. e5- 1 p. |
artikel |
6 |
Country in Focus: diabetes prevalence on the rise in Turkey
|
Burki, Talha |
|
2016 |
4 |
5 |
p. 391-392 2 p. |
artikel |
7 |
Diagnosis of diabetes type in children and young people: challenges and recommendations
|
Amed, Shazhan |
|
2016 |
4 |
5 |
p. 385-386 2 p. |
artikel |
8 |
Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications
|
Stefan, Norbert |
|
2016 |
4 |
5 |
p. 457-467 11 p. |
artikel |
9 |
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
|
Wu, Jason H Y |
|
2016 |
4 |
5 |
p. 411-419 9 p. |
artikel |
10 |
Growth monitoring as an early detection tool: a systematic review
|
Scherdel, Pauline |
|
2016 |
4 |
5 |
p. 447-456 10 p. |
artikel |
11 |
Health-care access of transgender people: a medical student approach
|
Pelzer, Benedikt W |
|
2016 |
4 |
5 |
p. 388-389 2 p. |
artikel |
12 |
Healthy-food procurement: using the public plate to reduce food insecurity and diet-related diseases
|
Freudenberg, Nicholas |
|
2016 |
4 |
5 |
p. 383-384 2 p. |
artikel |
13 |
Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
|
Sattar, Naveed |
|
2016 |
4 |
5 |
p. 403-410 8 p. |
artikel |
14 |
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial
|
Cooper, Cyrus |
|
2016 |
4 |
5 |
p. 393-402 10 p. |
artikel |
15 |
mHealth plus community health worker interventions: the future research agenda
|
Mishra, Shiva Raj |
|
2016 |
4 |
5 |
p. 387-388 2 p. |
artikel |
16 |
mHealth plus community health worker interventions: the future research agenda – Author's reply
|
Rubinstein, Adolfo |
|
2016 |
4 |
5 |
p. 388- 1 p. |
artikel |
17 |
PCSK9 inhibition in type 2 diabetes: so far so good, but not there yet
|
Santos, Raul D |
|
2016 |
4 |
5 |
p. 377-379 3 p. |
artikel |
18 |
Recent advances in the pharmacological management of hypercholesterolaemia
|
Ajufo, Ezim |
|
2016 |
4 |
5 |
p. 436-446 11 p. |
artikel |
19 |
Research capacity in Africa—will the sun rise again?
|
Davies, Justine |
|
2016 |
4 |
5 |
p. 375- 1 p. |
artikel |
20 |
Research in brief
|
Kang, Seema |
|
2016 |
4 |
5 |
p. 390- 1 p. |
artikel |
21 |
SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?
|
Wilding, John |
|
2016 |
4 |
5 |
p. 379-381 3 p. |
artikel |
22 |
Towards a trial-based definition of vitamin D deficiency
|
Reid, Ian R |
|
2016 |
4 |
5 |
p. 376-377 2 p. |
artikel |